LeadStory

CBS America

Changes to "black box" warnings on hormone therapies for menopause

CBS America · Just In
CBS America
CBS America
Just In

FDA commissioner Dr. Marty Makary joins "CBS Mornings" to discuss the agency's announcement Thursday that boxed warnings will be removed from many estrogen products used for hormone therapy, a treatment that helps alleviate the symptoms of menopause.

Breakdown
  • The FDA will remove black box warnings from many menopause hormone therapies, potentially benefiting tens of millions of women. 22s
  • Black box warnings have been on estrogen-containing menopause treatments since 2003, warning of increased risks of breast cancer, stroke, and dementia. 31s
  • FDA Commissioner Dr. Marty McCary says new data show these treatments are safe and provide many health benefits, including improved quality of life. 46s
  • A government study over 20 years ago led to a decline in hormone therapy use, but recent evidence does not show increased breast cancer mortality. 3m 7s
  • The FDA expects that removing the warning labels will make it easier for women and doctors to discuss hormone therapy as a treatment option. 5m 17s
Health